Patents for A01K 67 - Rearing or breeding animals, not otherwise provided for; New breeds of animals (34,042)
06/2006
06/28/2006CN1261589C A beta-peptide screening method
06/28/2006CN1261021C Hybrid method of Afria crucia carp and mandarin fish
06/27/2006US7067715 Using expression vector comprising mouse coat color reporter and enhanced regulatory sequences to generate transgenic rodents which function as bioreactors for biosynthesis of heterologous proteins
06/27/2006US7067714 N-calcium channel knockout animal
06/27/2006US7067713 C1 Inhibitor produced in the milk of transgenic non-human mammals
06/27/2006US7067712 Transgenic animal; animal models; gene expression; skin disorders
06/27/2006US7067648 Regulatory sequences of the mouse villin gene—use in transgenesis
06/27/2006US7067308 Vector for genetically modifying non-human animals
06/27/2006US7067281 Mammalian IAP gene family, primers, probes and detection methods
06/27/2006CA2263729C Process for producing mammals with defined genetic properties
06/22/2006WO2006066089A1 Humanized amyloid beta antibodies for use in improving cognition
06/22/2006WO2006065975A2 Methods of treating ankylosing spondylitis using anti-tnf antibodies and peptides of human tumor necrosis factor
06/22/2006WO2006064197A2 Transgenic animals for assessing drug metabolism and toxicity
06/22/2006WO2006064007A1 Transgenic animal models for neurodevelopmental disorders
06/22/2006WO2006034832A3 Use of igfbp-2 in senescence diseases and for the maintenance of organ functions
06/22/2006US20060137031 Transgenic mice containing retinoid X receptor interacting protein gene disruptions
06/22/2006US20060137030 Protein tyrosine phosphatase RPTP-beta disruptions, compositions and methods relating thereto
06/22/2006US20060137029 Novel G protein-coupled receptor encoding gene and diagnostic uses therefor
06/22/2006US20060135456 Methods and compositions for RNA interference
06/22/2006US20060135419 Proteins involved in the regulation of energy homeostasis
06/22/2006US20060134780 For producing high affinity, fully human antibodies of a desired isotype in response to immunization with any virtually any desired antigen
06/22/2006US20060134655 Introducing a polynucleotide expressing a cGMP-visualizing probe into cells, whereby the cGMP-visualizing probe is expressed and made to coexist with cGMP; measuring the change in fluorescence wavelength
06/22/2006US20060134114 Novel human kallikrein-like genes
06/22/2006CA2590337A1 Humanized amyloid beta antibodies for use in improving cognition
06/22/2006CA2590010A1 Transgenic animals for assessing drug metabolism and toxicity
06/21/2006EP1672368A1 Diagnostic and therapeutic epitope and transgenic plant
06/21/2006EP1672365A1 Means and methods for determining and/or influencing cellular transportation
06/21/2006EP1672076A1 Method of constructing transgenic bird using lentivirus vector and transgenic bird obtained thereby
06/21/2006EP1670943A2 Diagnostic and therapeutic use of a sulfotransferase for neurodegenerative diseases
06/21/2006EP1670415A2 Animal model for protease activity and liver damage
06/21/2006EP1670308A1 Chimeric cancer models
06/21/2006EP1420646B1 Antimicrobial agent
06/21/2006EP1252315B1 Method for the production of a protein
06/21/2006CN1791421A Method for inducing mammary epithelial cell differentiation
06/21/2006CN1789416A Human artificial chromosome containing human antibody lambda light chain
06/21/2006CN1788696A Emulated ecological environment breeding method and device for giant salamander
06/21/2006CN1259826C Method for breeding telenomus B. madarina using output egg of punctatus
06/21/2006CN1259825C Method for promoting parasitic rate of telenomus B.madarina in output egg of punctatus
06/21/2006CN1259824C Method for promoting parasitic rate of telenomus B.madarina in dissected egg of punctatus
06/20/2006US7064245 Process for reconstructing a non-human mammalian embryo by nuclear transfer using a heat treated donor nucleus and preparaing a non-human mammal
06/20/2006US7064244 Transgenic mammals having human Ig loci including plural VH and VK regions and antibodies produced therefrom
06/20/2006US7064243 Transgenic roundworm for monitoring inhibitors of protein secretion pathways; parasiticides; disease resistant plants
06/20/2006US7063964 Nucleic acids encoding IL-12 antibody
06/15/2006WO2006063182A2 Orthopic reconstituted human breast tumor model in mouse
06/15/2006WO2006062507A1 Methods of prescreening cells for nuclear transfer procedures
06/15/2006WO2006062135A1 Diagnostic for mental disease
06/15/2006WO2006062134A1 Ip3 receptor-deficient mouse
06/15/2006WO2006060898A1 Method for treating inflammatory disorders
06/15/2006WO2006047367A3 Suppression of endogenous immunoglubolin expression in non-human transgenic animals
06/15/2006WO2006031132A3 Animals for conserving n-3 highly unsaturated fatty acids.
06/15/2006WO2005123923A3 Inducer specific tetracycline repressor proteins and methods of use thereof
06/15/2006WO2005116070A3 Reporter system for detecting signal pathway activation in multiple cell types
06/15/2006WO2005112621A3 A murine model of hiv-1 infection
06/15/2006US20060130170 Avian transgenesis using a chicken ovalbumin gene region
06/15/2006US20060130169 Transgenic non-human mammals that reproduce human pathologies of stem cell origins, such as chromosomal anomalies associated with chronic myeloid leukemia, B-cell acute lymphoblastic leukemia, T-cell acute or lymphoblastic leukemia, or with the migration of hematopoietic or embryonic stem calls.
06/15/2006US20060130168 Using transgenic non-human mammals that reproduce human pathologies of stem cell origins, such as chromosomal anomalies associated with chronic myeloid leukemia, B-cell acute lymphoblastic leukemia, T-cell acute or lymphoblastic leukemia, or with the migration of hematopoietic or embryonic stem cells
06/15/2006US20060130167 Transgenic non-human mammals as models for human pathologies of stem cell origin
06/15/2006US20060130166 Transgenic non-human mammals as models for human pathologies of stem cell origin
06/15/2006US20060130165 F066 transgenic mice that express pathogenic mutants of the sca2 gene
06/15/2006US20060130164 Toll/interleukin-1 receptor adapter protein (TIRAP)
06/15/2006US20060130163 Method of performing trangenesis
06/15/2006US20060130162 Shrimp and the production thereof
06/15/2006US20060130161 Animal model systems for viral pathogenesis of neurodegeneration, autoimmune demyelination, and diabetes
06/15/2006US20060130160 Full-length human cDNAs encoding potentially secreted proteins
06/15/2006US20060130159 Method of purifying recombinant MSP 1-42 derived from Plasmodium falciparum
06/15/2006US20060130158 Modified transferrin fusion proteins comprising duplicate transferrin amino or carboxy terminal domains
06/15/2006US20060130157 Ungulates with genetically modified immune systems
06/15/2006US20060127927 Mammalian IAP gene family, primers, probes, and detection methods
06/15/2006US20060127923 Internal ribosomal entry site mediated gene expression
06/15/2006US20060127455 Optimized food for expressing luminescent proteins in animals
06/15/2006US20060124063 Aquaculture of marine worms
06/14/2006EP1667516A1 Method of selecting animal models from animals which have been subject to mutagenesis, and the use of myb transcription factors for screening
06/14/2006EP1097210B1 Immunological reagent specifically interacting with the extracellular domain of the human zeta chain
06/14/2006CN1788079A Method for separating and cultiviting human multifunctional embryo stem cell
06/14/2006CN1787739A Sperm cell process system
06/14/2006CN1784958A Semi-wild stocking method of musk deers
06/14/2006CN1258974C Silkworm silk gland protection type dyestuff and process for making same
06/13/2006US7060871 Use of exogenous β-adrenergic receptor and β-adrenergic receptor kinase gene constructs to enhance myocardial function
06/13/2006US7060869 Fluorescent indicator for use as tool in genetic engineerging
06/13/2006US7060868 Autoimmune disease model animal
06/13/2006US7060500 Single-stranded oligodeoxynucleotide mutational vectors
06/13/2006US7060499 causes recombination reaction between two mutant FRT sequences having an identical sequence to each other but does not cause recombination reaction with a wild-type FRT sequence, in the presence of FLP recombinase
06/13/2006US7060496 Culture medium for in vitro culture of in vitro-produced porcine embryo and method for in vitro production of porcine embryo using the culture medium
06/13/2006US7060495 Polypeptide for use in as anticarcinogenic agent
06/13/2006US7060481 Comprises peptide for diagnosing and treating inflammatory, tumor, arthritic and nervous system disorders
06/13/2006US7060449 Method of preparing GALR2 receptors composition
06/13/2006US7060249 Obtaining and identifying drosophila neurodegeneration mutant which demonstrates temperature-sensitive and bang-sensitive paralysis phenotypes; neuroprotectants
06/08/2006WO2006060603A2 Sex-specific automated sorting of non-human animals
06/08/2006WO2006021800A3 Tumour model
06/08/2006WO2006017788A3 TRANSGENIC HFN4α MICE EXPRESSING THERAPEUTIC TARGET AF1 DOMAINS AND THEIR METHODS OF USE AS MODELS FOR METABOLIC DISORDERS
06/08/2006WO2006016135A3 Enhanced aquaculture feeds
06/08/2006WO2006001021A3 Chimeric avian-based screening system containing mammalian grafts
06/08/2006US20060123504 Methods of producing polyclonal antibodies
06/08/2006US20060123503 V1a arginine vasopressin receptor disruptions, compositions and methods relating thereto
06/08/2006US20060123502 Assay methods for identifying RE2-like antagonists, methods of use, and non-human transgenic animals
06/08/2006US20060123501 Method for treating inflammatory disorders
06/08/2006US20060123500 Methods of prescreening cells for nuclear transfer procedures
06/08/2006US20060123499 Civet animal model system for Severe Acute Respiratory Syndrome (SARS) coronavirus infection and uses thereof
06/08/2006US20060123498 Paks as modifiers of the chk pathway and methods of use
06/08/2006US20060123497 Sperm-specific cation channel, catsper-4, and uses therefor